169 related articles for article (PubMed ID: 24729090)
1. Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis.
Wang HL; Zhou PY; Liu P; Zhang Y
Tumour Biol; 2014 Jul; 35(7):6815-21. PubMed ID: 24729090
[TBL] [Abstract][Full Text] [Related]
2. Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies.
Wang HL; Zhou PY; Zhang Y; Liu P
Cancer Biother Radiopharm; 2014 May; 29(4):166-72. PubMed ID: 24784911
[TBL] [Abstract][Full Text] [Related]
3. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
[TBL] [Abstract][Full Text] [Related]
4. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.
Guo L; Yang TF; Liang SC; Guo JX; Wang Q
Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
8. [Fragile histidine triad expression in rhabdomyosarcoma].
Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
[TBL] [Abstract][Full Text] [Related]
9. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
[TBL] [Abstract][Full Text] [Related]
10. Relationship between abnormality of FHIT gene and EBV infection in gastric cancer.
Xiao YP; Han CB; Mao XY; Li JY; Xu L; Ren CS; Xin Y
World J Gastroenterol; 2005 Jun; 11(21):3212-6. PubMed ID: 15929169
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis.
Zhai JH; Gu WC; Xu XL; Wu J; Hu XJ; Hou KZ
Tumour Biol; 2015 Feb; 36(2):701-9. PubMed ID: 25286754
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.
Wang D; Guo XZ; Li HY; Zhao JJ; Shao XD; Wu CY
Tumour Biol; 2014 Oct; 35(10):10301-7. PubMed ID: 25034525
[TBL] [Abstract][Full Text] [Related]
13. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma.
Otero-Garcia JE; Youssef E; Enamorado II; Du W; Yoo GH; Merati K; Kewson D; Lonardo F; Jacobs JR; Kim H
Am J Otolaryngol; 2004; 25(4):231-9. PubMed ID: 15239028
[TBL] [Abstract][Full Text] [Related]
15. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
[TBL] [Abstract][Full Text] [Related]
18. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
19. Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen R; He G; Gao JX
Int J Clin Exp Pathol; 2010 May; 3(5):482-91. PubMed ID: 20606729
[TBL] [Abstract][Full Text] [Related]
20. Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.
Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
